Japan Orthobiologics Market Outlook to 2025

Japan Orthobiologics Market Outlook to 2025


  • Products Id :- GDMECC3245DB
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Japan Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, Japan Orthobiologics Market Outlook to 2025, provides key market data on the Japan Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the Japan Orthobiologics market.

- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Orthobiologics Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Orthobiologics Market, Japan 8

3.1 Orthobiologics Market, Japan, Revenue (USDm), 2015-2025 8

3.1.1 Bone Grafts and Substitutes Market, Japan, Revenue (USDm), by Segment, 2015-2025 11

3.1.2 Bone Growth Stimulators Market, Japan, Revenue (USDm), by Segment, 2015-2025 13

3.1.3 Soft Tissue Biologics Market, Japan, Revenue (USDm), by Segment, 2015-2025 15

3.1.4 Viscosupplementation Market, Japan, Revenue (USDm), by Segment, 2015-2025 17

3.2 Orthobiologics Market, Japan, Volume (Units), 2015-2025 19

3.2.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2015-2025 22

3.2.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2015-2025 24

3.2.3 Soft Tissue Biologics Market, Japan, Volume (Units), by Segment, 2015-2025 26

3.2.4 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2015-2025 28

3.3 Orthobiologics Market, Japan, Average Price (USD), 2015-2025 30

3.4 Orthobiologics Market, Japan, Distribution Share by Revenue (USDm), 2017 32

3.5 Orthobiologics Market, Japan, Company Share by Revenue (USDm), 2017 33

4 Overview of Key Companies in Japan, Orthobiologics Market 35

4.1 Seikagaku Corp 35

4.1.1 Company Overview 35

4.2 Chugai Pharmaceutical Co Ltd 35

4.2.1 Company Overview 35

4.3 DePuy Synthes Inc 35

4.3.1 Company Overview 35

4.4 Stryker Corp 35

4.4.1 Company Overview 35

4.5 Medtronic Plc 36

4.5.1 Company Overview 36

4.6 Sanofi 36

4.6.1 Company Overview 36

4.7 Zimmer Biomet Holdings Inc 36

4.7.1 Company Overview 36

5 Orthobiologics Market Pipeline Products 37

6 Financial Deals Landscape 39

6.1 Partnerships 39

6.1.1 Medinet Enters into Licensing Agreement with Histogenics 39

7 Recent Developments 40

7.1 Financial Announcements 40

7.1.1 Apr 26, 2018: Kyocera Announces Financial Results for Year Ended March 31, 2018 40

7.1.2 Mar 29, 2018: Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment 40

7.1.3 Mar 28, 2018: Ipsen Announces EMA Validation of Filing of a New Application for Additional Indication for Cabometyx, for patients with previously treated advanced Hepatocellular Carcinoma (HCC) 42

7.1.4 Mar 27, 2018: Constant Pharmaceuticals Announces European Patent Issuance for TXA127 in Treatment of Stroke 43

7.1.5 Mar 22, 2018: SelectHealth Signs Value-based Contract With Novo Nordisk 43

8 Appendix 45

8.1 Research Methodology 46

8.1.1 Coverage 46

8.1.2 Secondary Research 46

8.1.3 Primary Research 47

8.1.4 Market Modeling and Forecasting 48

8.1.5 Company Share Analysis 49

8.1.6 Distribution Share Analysis 50

8.1.7 Benchmarking 50

8.2 GlobalData Consulting 50

8.3 Contact Us 51

8.4 Disclaimer 51

1.2 List of Figures

Figure 1: Orthobiologics Market, Japan, Revenue (USDm), USD Constant, 2015-2025 8

Figure 2: Bone Grafts and Substitutes Market, Japan, Revenue (USDm), USD Constant, 2015-2025 11

Figure 3: Bone Growth Stimulators Market, Japan, Revenue (USDm), USD Constant, 2015-2025 13

Figure 4: Soft Tissue Biologics Market, Japan, Revenue (USDm), USD Constant, 2015-2025 15

Figure 5: Viscosupplementation Market, Japan, Revenue (USDm), USD Constant, 2015-2025 17

Figure 6: Orthobiologics Market, Japan, Volume (Units), 2015-2025 19

Figure 7: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2025 22

Figure 8: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2025 24

Figure 9: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2025 26

Figure 10: Viscosupplementation Market, Japan, Volume (Units), 2015-2025 28

Figure 11: Orthobiologics Market, Japan, Company Share (%) 2017 33

1.1 List of Tables

Table 1: Orthobiologics Market, Japan, Revenue (USDm), USD Constant, 2015-2020 9

Table 2: Orthobiologics Market, Japan, Revenue (USDm), USD Constant, 2021-2025 10

Table 3: Bone Grafts and Substitutes Market, Japan, Revenue (USDm), USD Constant, 2015-2020 12

Table 4: Bone Grafts and Substitutes Market, Japan, Revenue (USDm), USD Constant, 2021-2025 12

Table 5: Bone Growth Stimulators Market, Japan, Revenue (USDm), USD Constant, 2015-2020 14

Table 6: Bone Growth Stimulators Market, Japan, Revenue (USDm), USD Constant, 2021-2025 14

Table 7: Soft Tissue Biologics Market, Japan, Revenue (USDm), USD Constant, 2015-2020 16

Table 8: Soft Tissue Biologics Market, Japan, Revenue (USDm), USD Constant, 2021-2025 16

Table 9: Viscosupplementation Market, Japan, Revenue (USDm), USD Constant, 2015-2020 18

Table 10: Viscosupplementation Market, Japan, Revenue (USDm), USD Constant, 2021-2025 18

Table 11: Orthobiologics Market, Japan, Volume (Units), 2015-2020 20

Table 12: Orthobiologics Market, Japan, Volume (Units), 2021-2025 21

Table 13: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2020 23

Table 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2021-2025 23

Table 15: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2020 25

Table 16: Bone Growth Stimulators Market, Japan, Volume (Units), 2021-2025 25

Table 17: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2020 27

Table 18: Soft Tissue Biologics Market, Japan, Volume (Units), 2021-2025 27

Table 19: Viscosupplementation Market, Japan, Volume (Units), 2015-2020 29

Table 20: Viscosupplementation Market, Japan, Volume (Units), 2021-2025 29

Table 21: Orthobiologics Market, Japan, Average Price (USD), 2015-2020 30

Table 22: Orthobiologics Market, Japan, Average Price (USD), 2021-2025 31

Table 23: Orthobiologics Market, Japan, Distribution Share by Revenue (USDm), USD Constant, 2017 32

Table 24: Orthobiologics Market, Japan, Company Share by Revenue (USDm), USD Constant, 2017 34

Table 25: Orthobiologics Market Pipeline Products 37

Table 26: Medinet Enters into Licensing Agreement with Histogenics 39

Table 27: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Seikagaku Corp

Chugai Pharmaceutical Co Ltd

DePuy Synthes Inc

Stryker Corp

Medtronic Plc

Sanofi

Zimmer Biomet Holdings Inc

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag

select a license
Single User License
USD 4995 INR 349650
Site License
USD 9990 INR 699300
Corporate User License
USD 14985 INR 1048950

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com